Westwood Squibb Pharmaceuticals
As of the edition of 20 October 2026, Westwood Squibb Pharmaceuticals runs 11 drugs, 11 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 11 |
| Total | 11 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Hydrocortisone | none listed | 5 |
| Triamcinolone acetonide | none listed | 3 |
| Erythromycin | none listed | 0 |
| Ammonium lactate | none listed | 0 |
| Chloroxine | none listed | 0 |
| Crotamiton | none listed | 0 |
| Halcinonide | none listed | 0 |
| Haloprogin | none listed | 0 |
| Hydrocortisone valerate | none listed | 0 |
| Methdilazine | none listed | 0 |
| Sulconazole | none listed | 0 |
A route B row is one company at one target.